TAM TRAN: Open Payments
NPI 1366124356 · MOBILE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$770 in 40 payments from 19 companies in 2025. Trend: 2023 $0 · 2024 $795 · 2025 $770
Food & beverage: $770
| Company | Payments | Amount |
|---|---|---|
| Eisai Inc. | 3 | $81 |
| AstraZeneca Pharmaceuticals LP | 4 | $78 |
| Lilly USA, LLC | 4 | $74 |
| Corcept Therapeutics | 2 | $68 |
| Novo Nordisk Inc | 3 | $63 |
| ABBVIE INC. | 4 | $58 |
| Exact Sciences Corporation | 3 | $53 |
| Lundbeck LLC | 2 | $40 |
| Axsome Therapeutics, Inc. | 2 | $40 |
| IBSA Pharma Inc. | 2 | $39 |
Products named: Leqembi, Korlym, FARXIGA, JARDIANCE, Cologuard Collection Kit, Ozempic, UBRELVY, VYEPTI.
Industry payments across AL — which companies pay providers there.
